Insiders Xenon Pharmaceuticals Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 12:29:18 2024-05-14 EDT			5-day change	1st Jan Change
41.22 ^USD	+1.82%		-4.79%	-10.23%

05-10	Wedbush Trims Xenon Pharmaceuticals' Price Target to $50 From $51, Maintains Outperform Rating	MT
05-09	Xenon Pharmaceuticals Q1 Net Loss Narrows	MT

Xenon Pharmaceuticals Inc. Announces Board Resignations	04-19	CI
Xenon Pharmaceuticals Insider Sold Shares Worth $330,290, According to a Recent SEC Filing	03-08	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $601,615, According to a Recent SEC Filing	03-08	MT
Xenon Pharmaceuticals Insider Sold Shares Worth $758,983, According to a Recent SEC Filing	12-15	MT
Insider Sell: Xenon Pharmaceuticals	23-08-24	MT
Xenon Pharmaceuticals Inc. Announces Board Appointments	23-08-08	CI
Insider Sell: Xenon Pharmaceuticals	23-05-30	MT
Xenon Pharmaceuticals Inc. Announces Appointment of Andrea Difabio as Chief Legal Officer and Corporate Secretary	22-11-07	CI
Insider Sell: Xenon Pharmaceuticals	22-09-07	MT
Insider Sell: Xenon Pharmaceuticals	22-09-02	MT
Insider Sell: Xenon Pharmaceuticals	22-08-16	MT
Insider Sell: Xenon Pharmaceuticals	22-08-16	MT
Xenon Pharmaceuticals Inc. Announces Michael Hayden Will Not Stand for Re-Election as Member of Board	22-06-01	CI
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Insider Sell: Xenon Pharmaceuticals	22-03-09	MT
Xenon Pharmaceuticals Inc. Appoints Christopher Kenney, M.D. as Chief Medical Officer	21-08-23	CI
Xenon Pharmaceuticals Inc. Announces Board Appointments	21-06-03	CI
Xenon Pharmaceuticals Inc Elects Ian Mortimer as Chief Executive Officer	21-06-03	CI
Insider Trends: Xenon Pharmaceuticals Insider Converts/Exercises Derivative Security, Sells for Taxes and Self, Buying Trend Remains Intact	21-06-01	MT

No results for this search